Bowmed Ibisqus is a privately owned pharmaceutical company specialising in the supply of generic injectable medicines to both NHS hospitals and the private healthcare sector.
Operating from our base in rural North Wales, our UK team is committed to delivering sustainable cost efficiencies while maintaining uncompromising quality standards.
Bowmed Ibisqus is a wholly owned subsidiary of the Ibigen Group, headquartered in Italy. For over 100 years, this family-owned group has been producing and distributing injectable products worldwide.
As a leader in the production of β-lactam antibiotics and hospital therapy products, Ibigen is recognised for its expertise in aseptic dosing and β-lactam formulations. The group operates as a fully integrated, vertical company managing every stage from product development and regulatory registration to raw material sourcing, finished product manufacturing and sales distribution.
